PharmaTher Announces FDA Approval of Ketamine (KETARx(TM))
PharmaTher Announces FDA Approval of Ketamine (KETARx(TM)) GlobeNewswire August 11, 2025 TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce today that the U.S. Food and Drug Administration (FDA) has […]